Retrospective studies indicated that baseline nutrition- and inflammation-related markers—such as high prealbumin, reduced CRP, and favorable indices such as PNI—were strongly linked to improved progression-free survival in advanced esophageal cancer patients receivingPD-1 blockade and chemotherapy [37]. The gene discussed is TTR; the disease is esophageal cancer.